Communicable Disease Threat Report, week 2, 10-16 January 2016

Scientific and technical publications
Publication series: Communicable Disease Threats Report (CDTR)
Time period covered: 10 - 16 January 2016

​The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals about active public health threats. This issue covers the period 10-16 January 2016 and includes updates on MERS, Ebola virus disease, Zika virus and the influenza 2015-2016 season.

Executive Summary

This issue covers the period 10–16 January 2016, and includes updates on Zika virus infection, Ebola virus disease and Middle East respiratory syndrome – coronavirus.

Ebola virus disease – West Africa 

On 15 January, WHO confirmed a new sporadic case of Ebola virus disease in Sierra Leone. The country was previously declared Ebola-free on 7 November 2015. On 14 January, WHO declared the end of the most recent outbreak of EVD in Liberia. Rapid Risk Assessment: Outbreak of Ebola Virus disease in West Africa – 13th update

Zika – Multistate (world)

Zika virus infections (ZIKV) continue to spread to previously unaffected areas of the world. Possible links between ZIKV infection in pregnancy and microcephaly of the foetus have been under investigation since October 2015 when the Brazilian Ministry of Health reported on an unusual increase in cases of microcephaly after the ZIKV outbreak in the north eastern states. Similar findings have also been reported from French Polynesia. Rapid risk assessment on Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome - 10 December 2015

Middle East respiratory syndrome – coronavirus (MERS C0V) - Multistate

During the past week, Saudi Arabia reported two additional cases of MERS-CoV. On 13 January, two cases of MERS-CoV were detected in the United Arab Emirates. Rapid risk assessment on severe respiratory disease associated with Middle East respiratory syndrome coronavirus- 21st update – 21 October 2015 (MERS-CoV)